In an animal model of inflammatory bowel disease (IBD), TGF-β1 containing imDCs EXO abrogated the disease severity and clinical manifestations while inhibiting Th17 responses and upregulating T-regulatory cells (Tregs) [172]. This evidence concerns the gene TGFB1 and inflammatory bowel disease.